PSMA Prostate Cancer Treatment | Radioligand Therapy (RLT) скачать в хорошем качестве

PSMA Prostate Cancer Treatment | Radioligand Therapy (RLT)

This video explains how prostate-specific membrane antigen (PSMA)-targeted treatment works and when it may be used to treat prostate cancer. PSMA-targeted radioligand therapy (also known as PSMA-targeted RLT) is a type of treatment that uses a radioactive drug (also called a radiopharmaceutical) that attaches to PSMA proteins on cancer cells and destroys their DNA, stopping them from growing or spreading. Discover how PSMA-targeted RLT for prostate cancer works, who may be eligible, and what to know about its benefits and potential side effects. This is not medical advice. This video is for educational purposes only. Always consult your doctor before making any medical decisions. Topics discussed: - What PSMA is and how it’s used in targeted therapy - How PSMA-targeted radiopharmaceuticals deliver radiation to cancer cells - Why this therapy causes less damage to healthy tissues - Who may qualify for PSMA-targeted RLT (including patients with metastatic castration-resistant prostate cancer, or mCRPC) - The role of PSMA PET scans in treatment planning - Potential benefits and possible side effects of PSMA-targeted RLT #PSMAprostatecancertreatment #PSMAtreatment #prostatecancerrlt #radioligand #PRIMR @doctorgrewexplainscancer1251 ‪@zeroprostatecancer‬